Moreover, pulmonary delivery of DNase‐I/HSA NMs exerted greater efficacy than free DNase‐I in treating sepsis‐associated ALI, which significantly improved survival rate and attenuated lung injury via efficient scavenging of cf‐mtDNA. Here, DNASE1 is linked to acute respiratory distress syndrome.